This work integrates the opinion on the current use of cenobamate (CNB) of an expert panel structured across seven thematic domains: efficacy, patient profiles, titration and dosing, pharmacokinetic interactions, safety, parallel effects, and therapeutic positioning. According to personal experience and scientific evid...
M. Toledo, V. Villanueva, I. García Morales et al.· Neurological Therapeutics· 0 citations
Key Points Question Does azetukalner, a novel, potent KV7 channel opener, effectively reduce seizure frequency in adults experiencing focal seizures despite established treatment with up to 3 antiseizure medications at baseline? Findings This randomized clinical trial among 374 participants found that treatment with az...
Jacqueline A. French, W. LaFrance, P. Ryvlin et al.· JAMA Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.